These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4455968)

  • 21. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broad sensitivity of rodent arrhythmia models to class I, II, III, and IV antiarrhythmic agents.
    Brooks RR; Miller KE; Carpenter JF; Jones SM
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):201-9. PubMed ID: 2726785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 24. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E; Viana AP
    Arzneimittelforschung; 1968 Feb; 18(2):175-9. PubMed ID: 5695375
    [No Abstract]   [Full Text] [Related]  

  • 25. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate.
    Hope RR; Williams DO; el-Sherif N; Lazzara R; Scherlag BJ
    Circulation; 1974 Sep; 50(3):507-14. PubMed ID: 4416250
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antiarrhythmic effects of crebanine].
    Yu ZP; Mu YS; Zhao ZX; Wang FC
    Zhongguo Zhong Yao Za Zhi; 1992 Nov; 17(11):685-7, 704. PubMed ID: 1301759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    Clin Pharmacol Ther; 1970; 11(4):460-80. PubMed ID: 4913865
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modification of ouabain-induced arrhythmia test in anesthesized guinea pigs].
    Luca C; Sardi B; Valli L; Pacei E
    Cardiologia; 1987 Jan; 32(1):85-8. PubMed ID: 3107817
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of cardiac arrhythmias.
    Han J
    Am Fam Physician; 1976 Jan; 13(1):128-38. PubMed ID: 1251787
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations on models used for the evaluation of antiarrhythmic drugs.
    Baum T; Eckfeld DK; Shropshire AT; Rowles G; Varner LL
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):149-70. PubMed ID: 5111320
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias.
    Sakai K; Yamazaki T; Takagi M
    Tohoku J Exp Med; 1987 Apr; 151(4):443-51. PubMed ID: 3617055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 36. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative evaluation of the antiarrhythmic effect of derivatives of diphenylacetic acid and novocaine amide].
    Serdiuk EN; Koval'chuk LA
    Farmakol Toksikol; 1971; 34(2):168-70. PubMed ID: 5563386
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiarrhythmic activity of racemic propranolol and its optical isomers in ouabain-induced cardiac arrhythmias in rhesus monkeys.
    Narula SP; Sharma PL; Wahi PL
    Indian J Med Res; 1975 Dec; 63(12):1705-11. PubMed ID: 818008
    [No Abstract]   [Full Text] [Related]  

  • 39. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
    Mest HJ; Thomsen P; Raap A
    Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.